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Abstract
Background: Subclinical endotoxemia has been reported in HIV-1 infected persons and may drive systemic immune
activation and pathogenesis. Proinflammatory responsiveness to endotoxin (LPS) is mediated by Toll-like receptor 4 (TLR4).
We therefore examined the association between plasma LPS levels, HIV RNA, and TLR4 expression and cytokine responses in
the blood of HIV infected and uninfected participants in a cohort of female sex-workers in Kenya.
Methodology/Principal Findings: Ex vivo plasma and peripheral blood mononuclear cells (PBMC) were assessed for LPS
and TLR mRNA, respectively. The effects of HIV single stranded RNA, a TLR8 ligand, on TLR4 and LPS signaling were further
assessed in short term PBMC culture. Both HIV uninfected and infected subjects frequently had low detectable LPS levels in
their plasmas. Significantly increased LPS levels were associated with chronic HIV-1 infection, both treated and untreated,
but not with other acute or semi-chronic conditions reported. In HIV-uninfected subjects, TLR4 mRNA expression levels
correlated inversely with plasma LPS levels, suggesting chronic endotoxin ‘tolerance’ in vivo. A similar effect of reduced
TLR4 mRNA was seen in short term PBMC culture after stimulation with LPS. Interestingly, the apparent in vivo tolerance
effect was diminished in subjects with HIV infection. Additionally, pre-stimulation of PBMC with LPS lead to proinflammatory
(TNF-a) tolerance to subsequent LPS stimulation; however, pre-treatment of PBMC with HIV single-stranded RNA40, could
enhance TLR4-mediated LPS responsiveness in vitro.
Conclusions/Significance: Thus, dysregulation of endotoxin tolerance by HIV-1 RNA may exacerbate HIV chronic immune
activation and pathogenesis.
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Introduction
Lipopolysaccharide (LPS or endotoxin) is a component of Gram
negative bacterial cell walls and is known to induce large
proinflammatory responses that cause bacterial sepsis[1]. Recent-
ly, increased levels of LPS have been found in the plasma of
chronically HIV-1 infected individuals who did not demonstrate
overt signs of sepsis [2]. The source of the circulating endotoxin is
thought to be from ‘microbial translocation’ of bacterial products
across the gastrointestinal tract since HIV and SIV are known to
induce dramatic cellular changes in the gastrointestinal mucosa
[3,4]. This has not, however, been explored in African populations
where enteric microflora and opportunistic infections may be
different and the HIV pandemic is at its peak. Whatever the
endotoxin source, subclinical endotoxemia could be a substantial
driving force for chronic immune activation in HIV which has
been linked to disease progression[5].
Microbes that invade the external physical barriers of mamma-
lian hosts are recognized instantly by sensors of the innate immune
system. Toll-likereceptors (TLR),for instance,which areembedded
in host immune cell membranes and intracellular compartments,
recognize these microbial or pathogen associated molecular
patterns (PAMPs)[6]. LPS was the prototypic proinflammatory
microbial signaling molecule shown to induce the mammalian Toll
pathway[7], and the receptor was later identified as TLR4. More
recently, short GU rich sequences of HIV-1 RNA were the first
described natural ligands for TLR7 and TLR8[8,9,10]. Many
human cell types express various TLR, especially those that have
innate immune or barrier function. Peripheral blood mononuclear
cells (PBMC) are composed of circulating immune cells including
lymphocytes, monocytes, and dendritic cells that are rich in TLR
expression[11] and respond broadly to TLR ligands. Both LPS and
HIV ssRNA have been linked to elevated immune activation levels
in chronic HIV infection[2,12].
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5644We recently reported that mRNA expression of multiple TLRs,
including TLR4, TLR7 and TLR8, are significantly increased in
PBMCs of subjects chronically infected with HIV-1[13]. A
proinflammatory consequence is inferred, since TNF-a responses
induced by LPS and HIV ssRNA were also higher in PBMC
isolated from HIV infected subjects than from uninfected controls.
We also identified a weak association between the increased TLR
expression and plasma viral load, suggesting that viral products or
viral replication may drive these TLR signaling changes. We
hypothesized that HIV ssRNA may play a role in regulating TLR
signaling. In this study, we sought to confirm the association
between HIV infection and sub-clinical endotoxemia in a cohort
of female sex-workers in Kenya, and evaluate TLR-mediated
signaling. We measured plasma endotoxin levels matched to TLR
expression levels and conducted in vitro studies to further evaluate
the effect of LPS and ssRNA on cross TLR proinflammatory
signaling.
Materials and Methods
Human subjects
HIV-1 infected and HIV uninfected women were recruited
from the Pumwani sex-worker cohort in Nairobi, Kenya [14]. All
subjects gave informed written consent and were sampled during
scheduled outpatient research visits. HIV infected subjects tested
seropositive on at least two HIV ELISA tests, at least 6 months
apart. Routine questionnaires including data on clinical symp-
tomatology, physician exam, and basic laboratory results were
collected on each visit. The study was approved by the
Institutional Review Boards of The University of Manitoba, and
the University of Nairobi through the Kenyatta National Hospital
ethical review committee. All clinical investigation was conducted
according to the principles of the Helsinki Declaration.
Sample acquisition and preparation
Peripheral blood was collected by venipuncture. Routine CD4
T cell counts were performed on all subjects using flow cytometry
(FACScan, BD) and available plasma viral loads were measured by
polymerase chain reaction (Roche bDNA). Cryopreserved plas-
mas, matched to our previous TLR study[13], were used in
endotoxin assays. For new samples, peripheral blood mononuclear
cells (PBMCs) were isolated from fresh blood by density gradient
centrifugation as previously described[13] and were used fresh for
in vitro culture studies or aliquotted and frozen in Trizol for TLR
quantitative reverse-transcriptase real time PCR (QRT-PCR).
Endotoxin assay
Plasma was first centrifuged to remove debris then diluted to
20% with endotoxin-free water and heated to 70uC for 10 min to
inactivate plasma proteins as previously described[2]. Plasma LPS
levels were then quantified using a commercially available Limulus
Amebocyte assay (Associates of Cape Cod) and analyzed with
background subtracted according to the package insert.
TLR expression
Total RNA was extracted from TRIzol samples containing
approximately 1610
6 PBMCs as per manufacturer instructions
(Invitrogen). The detailed protocol and TaqMan primers are
published elsewhere[13]. Readout of data was a ratio of the gene
quantity to its 18S rRNA quantity, defined as relative expression.
In vitro TLR stimulations
Freshly isolated PBMCs were cultured at 1610
6 cell/ml in
RPMI and either 0.1 ug/ml LPS (Invivogen), 1 ug/ml ssRNA40
(Invivogen), or media alone (RPMI and 10%FCS) for most studies.
For TLR-ligand ‘priming’ studies, supernatants from PBMC
culture were removed after 16 hours priming with either LPS or
ssRNA40, or media control. The primed cells were then washed
twice in RPMI, and replenished with fresh media and cultured
with LPS for a further 8 hours (post-prime LPS stimulation).
Additional priming studies were carried out using lower dose of
LPS (0.01 ug/ml) to examine a dose effect. Post-prime media
control assays ruled out significant cytokine carry-over from initial
TLR-ligand stimulations. Culture supernatants were diluted 10-
fold and assayed for cytokines using cytometric bead array (BD
Biosystems) on a FACScan flow cytometer (BD) as per the
manufacturers protocol. Cell pellets for Q-PCR TLR expression
studies were immediately frozen in Trizol.
Statistical analysis
Data were analyzed using SPSS, Microsoft Excel and Prism 5.0
software (GraphPad). Data from the FAScan (BD) was acquired
using the BD CBA acquisition software into Microsoft Excel and
the analyzed by Prism 4.0 software. Non-parametric tests were
used including Mann-Whitney tests for comparing independent
variables, Wilcoxon rank t-tests for paired samples, unpaired t tests
for replicate experiments, and Spearman’s rank test for matched
correlations. Chi squared (x
2) tests were used for analysis of
categorical variables (detectable endotoxemia) and associated
relative risks (RR) reported. Two tailed tests were used in all
analyses.
Results
Increased plasma endotoxin levels are associated with
HIV infection but not acute presenting conditions
Study participant characteristics for direct ex vivo studies are
shown in Table 1. Matched plasmas to PBMC were available from
HIV-uninfected (n=31), HIV-infected ART-naı ¨ve (n=38), and
HIV-infected on antiretroviral therapy (ART) (n=19) women.
Age and the level of sex-work activity were similar among these
groups. The CD4 T cell counts of the women taking ART were
lower than untreated subjects (P=0.008), due to the advanced
stages of disease in subjects initiating ART and insufficient time for
adequate CD4 T cell recovery (Median duration on ART 14
months, range 1–42). However, there was substantive suppression
of plasma HIV viral loads (mean drop 1.49 log10 copies/ml,
P,0.001) in subjects taking ART.
Plasma endotoxin levels were frequently detectable by LAL in
both HIV infected and uninfected subjects (level of detection 0.005
EU/ml). We confirmed that LPS levels were higher in plasma
from HIV-1 infected subjects compared with HIV-1 uninfected
Table 1. Characteristics of subjects participating in the in vivo
endotoxin studies, from the Pumwani sex-worker cohort.
HIV2 HIV+ ART
No. Subjects: n 31 38 19
Age: mean (range) 40.1 (24–62) 37.6 (27–62) 41.4 (25–62)
Sex clients per day: mean
(range)
4.4 (1–11) 5.1 (1–10) 3.9 (1–8)
CD4 count : mean (std dev.) 1,126 (318) 443 (253) 301 (131)
HIV RNA load: mean
Log10VL, std dev.)
n/a (n/a) 3.5 (.99) 2.0 (0.80)
doi:10.1371/journal.pone.0005644.t001
LPS-TLR Signaling in HIV
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ART (Figure 1A, Mean plasma endotoxin levels for HIV-
negative=0.011960.0196 EU/ml, HIV-positive untreat-
ed=0.018860.0199 EU/ml, P=0.022, and HIV-positive on
ART=0.024960.0210 EU/ml, P=0.009)). In this study, LPS
levels did not correlate with plasma viral load (R=20.0839,
P=0.593) nor CD4 T cell counts (R=0.0122, P=0.929).
The proportion of subjects with detectable endotoxemia was also
higher among subjects with HIV infection than those without
(Figure 1B, RR=1.45, P=0.048). Endotoxin levels in acute
symptomatic or physician diagnosed conditions during the study
visits are shown in Figure 1C. Although the study was not powered
to evaluate acute presenting conditions individually, there was no
trend toward increased endotoxemia when the acute conditions
were grouped (Figure 1D, RR=0.823, P=0.27). In fact, a higher
proportion of HIV infected subjects with detectable endotoxemia
did not have symptoms compared to those that did not have
detectable endotoxemia, though this was not statistically significant.
Tosummarize,inthesewomenofhighinfection-risk,chronicHIV-1
infection, whether treated or untreated, was associated with
endotoxemiathatwasunassociatedwithacutepresentationofillness.
TLR signaling and endotoxin tolerance
Endotoxin (LPS) sends proinflammatory signals primarily
through TLR4. Since tolerance to endotoxin is important in
preventing overwhelming inflammatory responses in advanced
sepsis[15], decreased proinflammatory signaling through chronic
or repetitive endotoxin exposure is expected. Here, we compared
basal TLR4 mRNA expression levels with plasma LPS levels in
matched plasmas and PBMCs from study subjects. In HIV
uninfected subjects (Figure 2A), a negative correlation between
TLR4 mRNA and plasma endotoxin levels was seen, however this
did not reach statistical significance (R=20.351, P=0.053).
However, in HIV infected subjects, no correlation or trend was
observed (R=0.0661, P=0.694). As previously described, TLR4
mRNA from PBMC was significantly associated with increased
HIV RNA load (Spearman R=0.326, P=0.049).
In short term in vitro culture, similar patterns of changes in TLR
expression were seen. Overnight LPS stimulation reduced TLR4
mRNA expression in PBMC from HIV uninfected subjects
(Figure 2B, P=0.009), but not from HIV infected subjects
(P=0.8078), who had a higher magnitude of TLR4 expression
at baseline. To summarize this data, direct patient samples (ex vivo)
and cell culture (in vitro) data suggest LPS functionally reduces
TLR4 expression, but HIV ssRNA induces TLR4 expression in
HIV uninfected subjects. However, this TLR4 expressional
regulation is not observed in HIV infected subjects. As previously
reported, (reshown in Figure 3 using different subjects), HIV
infection was also associated with higher proinflammatory TNF-a
responses in PBMC stimulated with LPS.
Figure 1. Plasma endotoxin (LPS) levels according to HIV status or presenting clinical condition. (A) Chronic HIV-1 infection was
significantly associated with increased plasma LPS levels in both untreated (Mean 0.0188EU/ml, P=0.023) and ART treated female sex-workers (Mean
0.0249, P=0.009) compared to uninfected controls (Mean 0.0119 EU/ml). (B) HIV infected subjects were also more likely to have detectable LPS
plasma levels than uninfected subjects (limit of detection 0.005 EU/ml, RR=1.45, P=0.048). (C) Symptomatic clinical conditions suggestive of acute
infectious etiologies were more frequent in HIV infected subjects than uninfected subjects. (D) However, the acutely reported or diagnosed
conditions were not independently associated with high plasma endotoxin levels (RR=0.823, P=0.274). Mann Whitney tests were used for
comparisons between groups, and Chi-squared for Relative Risk approximations (RR). Two tailed tests were used with level of significance *P,0.05,
**P,0.01.
doi:10.1371/journal.pone.0005644.g001
LPS-TLR Signaling in HIV
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functional TLR4 ‘tolerance’ (reduced proinflammatory responses
to LPS) or ‘priming’ (enhanced proinflammatory responses to
LPS), we performed a series of experiments as depicted in Figure 4.
Considerable variability in cytokine response levels was seen
between subjects and with various doses of LPS, but intra-subject
responses were consistent. Two patterns of responses, using the
same LPS dose as the TLR expression experiments above, 0.1 ug/
ml LPS, were observed as shown in Figure 4A and 4B which
depicts two experiments on PBMC from HIV uninfected subjects,
each run in triplicate. Shown first, pre-incubating with LPS
dramatically reduced subsequent LPS-induced TNF-a responses
(3% of media-primed response, P,0.0001). On the other hand,
pre-incubating with HIV ssRNA significantly enhanced LPS-
induced TNF-a responses (164% of media-primed response,
P=0.0011). In contrast to the TNF-a findings, production of
the immunoregulatory cytokine IL-10 was higher when pre-
incubated with LPS (184% of media-primed response, P=0.0039).
Pre-incubating with HIV ssRNA and stimulating with LPS led to a
statistically non-significant trend toward increased IL-10 produc-
tion compared to media-primed responses (P=0.098). The second
subject shown (Figure 4B) demonstrated similar LPS-induced
tolerance (P=0.0015), however, ssRNA primed TNF-a responses
were not significantly different from media-primed responses
(P=0.385). In this subject, HIV ssRNA priming trended toward
reducing the magnitude of the IL-10 response to LPS (P=0.056).
To assess the effect of endotoxin tolerance and reduced LPS levels,
we reduced the dose of LPS for stimulations to 0.01 ug/ml
(Figure 4C). In this case, LPS induced TLR tolerance was only a
trend in an HIV uninfected subject, and not significant in an HIV
infected subject. However, in both cases, pre-incubating with
ssRNA resulted in greatly enhanced LPS-induced TNF-a
responses (P,0.001 for both). Therefore, in vitro, LPS induced
proinflammatory tolerance to repeat LPS stimulation, at least at
higher doses, but HIV ssRNA often increased proinflammatory
responsiveness to LPS in PBMC (TLR priming).
Discussion
The data in these studies support that innate immune responses
are fundamentally altered in HIV infection, which may influence
chronic immune activation status and HIV disease. We previously
identified marked changes in TLR levels and signaling associated
with HIV infection[13]. Here we focused on the effect of HIV
infection and HIV RNA on endotoxin signaling. ‘Microbial
translocation’ of bacterial products from a disturbed gastrointes-
tinal tract has been proposed as a driver of HIV-associated chronic
immune activation[2], which in turn predicts progression to
AIDS[16]. Here, we confirmed, for the first time in an African
setting, the association between chronic HIV infection and
elevated plasma endotoxin levels. Interestingly, clinical symptoms
or conditions that could indicate acute underlying infections where
more frequent in HIV infected subjects, but asymptomatic HIV
infected subjects were at least as likely to have high plasma
endotoxin levels as those with symptoms or a diagnosed acute
infection. This is supportive of a chronic, sub-clinical cause for
‘walking endotoxemia’ in HIV infected individuals[16].
It is difficult from our study to determine the origin of plasma
endotoxin in non-HIV infected subjects. On further review of the
three HIV-uninfected subjects with the highest endotoxin levels,
one had a skin abscess (of which the causative agents are usually
Gram positive, thus not LPS producing), one had bacterial
Figure 2. In vivo and in vitro associations between endotoxin (LPS) levels and TLR4 mRNA expression in PBMCs. (A) In samples
obtained directly from HIV uninfected subjects, an inverse relationship between plasma LPS levels and TLR4 expression was apparent (R=20.35,
P=0.053, Spearman Rank correlation). However, in HIV infected subjects no correlation or trend was seen (R=0.029, P=0.83). Additionally, plasma
HIV RNA levels were positively associated with increased TLR4 mRNA levels (Spearman R=0.3260, P=0.049). (B) In a similar pattern, overnight culture
with 0.1 ug/l LPS reduced TLR4 mRNA expression in PBMC of HIV uninfected (n=70, P=0.009), but not infected subjects (n=21, P=0.627). Isolated
HIV ssRNA40 increased TLR4 mRNA expression in PBMC from HIV uninfected subjects (n=70, P=0.011), but not infected subjects (n=21, P=0.808).
Spearman rank sum and Wilcoxon signed rank tests were used, two-tailed ns=not significant, t=trend(P,0.1),*P,0.05.
doi:10.1371/journal.pone.0005644.g002
LPS-TLR Signaling in HIV
PLoS ONE | www.plosone.org 4 May 2009 | Volume 4 | Issue 5 | e5644vaginosis (which is non-invasive and unlikely to result in
bacteremia), and the other had no identifiable illness at
presentation. No other acute infectious etiologies were associated
with detectable plasma endotoxin levels. Other underlying
endemic infections such as with intestinal helminthes could be
present and easily missed[17], however. Additionally, vaginal
douching with detergents is a common practice of sex-workers in
Kenya[18], which could hypothetically disrupt the genital mucosa
and affect microbial translocation at this site, though this has not
been previously shown. Further studies are required to assess the
causes of subclinical endotoxemia in this and other populations,
and the consistency of these findings over time.
We assessed the effect of HIV infection and an HIV RNA
analogue on the central immune signaling receptor for LPS,
TLR4. Immune tolerance to overwhelming inflammatory stimuli,
as seen in overt sepsis[19], is necessary to prevent circulatory
collapse and death. In the case of chronic endotoxemia, little is
known about immune control mechanisms. Here we show, for the
first time, that chronic TLR4-mediated endotoxin tolerance is
likely, since (at the cusps of statistical significance) plasma
endotoxin levels were associated with decreased TLR4 mRNA
levels in peripheral blood, at least in HIV uninfected subjects. This
was further supported by in vitro data whereby PBMC culture in
the presence of LPS, significantly lowered expression of TLR4
mRNA compared to media controls. Conversely, as we previously
demonstrated, plasma HIV RNA levels in HIV infected subjects
were associated with increased TLR4 mRNA levels in PBMC.
This TLR4 mRNA enhancement was supported by in vitro culture
data using short HIV- single stranded RNA analog (ssRNA40).
Therefore, since both HIV viremia and low level endotoxemia are
likely to be persistently present in blood of HIV infected subjects,
with each appearing to have an opposing effect on TLR4 levels,
one could expect an altered TLR response in HIV infection.
Indeed, TLR4 mRNA levels in PBMC of HIV infected subjects
started at higher basal levels, and did not show evidence of
expressional tolerance on exposure to additional LPS or ssRNA.
Ag r e a t e rp r o i n f l a m m a t o r y( T N F - a)r e s p o n s et oL P Sw a s
associated with HIV infection in this study, as previously report-
ed[13]. To further evaluate the effect of HIV RNA on endotoxin
signaling, and TLR4, we pre-stimulated PBMC with HIV ssRNA or
LPS, before additional LPS stimulation. As expected, pre-stimulation
with LPS resulted in decreased TNF-a production to subsequent
LPS, compared to pre-stimulation with media alone, indicating
tolerance. On the other hand, pre-stimulating PBMC with HIV
ssRNA in most subjects resulted in higher TNF-a production to
subsequent LPS compared to media pre-stimulated controls. This
provided further evidence that HIV RNA was independently able to
enhance the proinflammatory response to endotoxin. Interestingly,
others have shown that LPS can drive HIV replication, even in the
face of tolerized endotoxin responses[20].
The mechanism by which HIV RNA influences TLR signaling
requires further evaluation. Feedback TLR expression, as
described here is one mechanism of immune regulation previously
described[21], but other mechanisms exist[22,23]. Also, produc-
tion of immune regulatory cytokine, IL-10, was induced at higher
levels in response to LPS than RNA40 in some subjects, but this
was not observed in others. Relative proportions of cell subsets
may also contribute to relative TLR quantities and responsiveness.
Although PBMC contain a mixture of immune cell types, each
possessing a variable expression of TLR, the overall responses to
endotoxin and HIV RNA appeared consistent and functionally
relevant. Further studies are warranted to delineate the TLR
signaling interactions in cellular subpopulations and tissue
dependence of cross-TLR signaling.
The implication of altered TLR responsiveness to endotoxin in
HIV infection is substantive. Chronic immune activation is a
strong predictor of HIV disease and death. Meier et al. suggested
that HIV RNA may lead to immune activation directly through
innate immune recognition by TLR8[10], and they demonstrated
that treatment with ART rapidly reduced immune activation
levels, paralleling HIV RNA suppression[12]. On the other hand,
Brenchley and others suggested that microbial translocation and
plasma endotoxemia are a cause of immune activation in
HIV[24]. In this latter case, the source of inflammatory ligand is
an indirect effect of HIV infection, and ART suppressive therapy
appears to only gradually and partially lead to correction of the
underlying process[25,26]. At this time that process is thought to
be gastrointestinal mucosal integrity. Importantly, if microbial
stimuli such as plasma LPS are drivers of immune activation and
ultimately contribute to CD4 T cell decline and HIV disease, then
viral suppressive therapy would only be expected to have limited
or delayed affect on CD4 recovery and prevention of opportunistic
infections. While this is sometimes the case, our data suggest that if
HIV RNA is a cause of enhanced proinflammatory response to
endotoxin, then by removing circulating HIV RNA, such as with
ART, normal tolerance to LPS could potentially be restored. In
other words, the response to persistent endotoxemia could be
dampened to normal or near normal levels. Indeed, many subjects
respond with rapid immune reconstitution to ART, in a time
frame unlikely to result from gastrointestinal mucosal repair, and
may result in part from reduced innate immune dysregulation
caused by circulating HIV RNA.
Figure 3. Effect of HIV-1 infection on proinflammatory cytokine
responses to endotoxin (LPS) in PBMC. In PBMC from HIV
uninfected (n=10) and HIV infected (n=9) subjects were cultured in
media alone or in the presents of 0.1 ug/ml LPS overnight and TNF-a
levels were determined in culture supernatants. Results are given as
fold TNF-a increases in LPS vs. media stimulated cells. Comparison is by
Mann-Whitney test. Two sided *P=0.017.
doi:10.1371/journal.pone.0005644.g003
LPS-TLR Signaling in HIV
PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5644Figure 4. In vitro endotoxin (LPS) ‘tolerance’ and TLR ‘priming’ of cytokine responses by single-stranded RNA. Data for triplicate
experiments in PBMCs from two HIV uninfected subjects are shown in (A and B) using 0.1 ug/ml of LPS, 1 ug/ml ssRNA40, or media alone for initial
priming and subsequent stimulation steps (e.g. ‘media-LPS’). In the first subject, pre-incubating PBMCs with LPS dramatically reduced subsequent
LPS-induced TNF-a responses (P,0.0001). However, pre-incubating with HIV ssRNA (RNA40) increased subsequent LPS-induced TNF-a responses
(P=0.0011) when compared with pre-incubating with culture media alone. Conversely, LPS pre-incubation resulted in higher endotoxin-induced IL-
10 responses than either media or HIV ssRNA-primed endotoxin stimulations (P=0.0039, P=0.025, and P=0.098). In a second subject (B), with lower
LPS-TLR Signaling in HIV
PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5644New techniques have enabled the detection of minute quantities
of diverse bacterial products in plasma and other typically sterile
sites[26,27]. The precise mechanisms, extent and effects of
microbial translocation in HIV are only starting to be worked
out[25,28,29,30,31]. Similarly, innate immune changes in acute
and chronic HIV infection are much less understood than their
adaptive immune counterparts[32]. This study indicates that
innate immune signaling, through TLR, is altered in HIV
infection. Specifically, HIV RNA may influence the response to
microbial translocation through TLR4 signaling, and promote or
enable the cycle of immune activation and burn out that ultimately
contributes to HIV immune dysfunction and AIDS. Better
understanding these mechanisms may lead to new approaches to
HIV and AIDS control.
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overall cytokine production from PBMC, LPS priming also reduced subsequent LPS induced TNF-a production (P=0.0015), but priming with ssRNA
did not result in significantly altered TNF-a responses (P=0.39). Also in the second subject, ssRNA primed PBMCs induced lower IL-10 to subsequent
LPS stimulation than media primed PBMCs at borderline statistical significance (P=0.056). (C) The same experiment design but with reduced LPS
levels to 0.01 ug/ml include one uninfected and one HIV infected subject. Lowering the LPS dose to 0.01 ug/ml resulted a trend toward LPS tolerance
in the uninfected subjects (P=0.097), but no significant tolerance in the HIV infected subjects (P=0.325). However, in both cases, pre-stimulating
PBMC with ssRNA40 dramatically enhanced subsequent LPS induced TNF-a (P,0.0001 for both). Between priming and the subsequent LPS
stimulations, PBMCs were washed to remove solublized cytokines; and carry-over cytokines tested were negligible. All experiments were run in
triplicate. Unpaired two tailed t tests were used. Level of significance ns=not significant, t=trend(P,0.1), *P#0.05, **P#0.01, and ***P#0.001.
doi:10.1371/journal.pone.0005644.g004
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